Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 104

1.
2.

A randomized comparison of all transretinoic acid (ATRA) followed by chemotherapy and ATRA plus chemotherapy and the role of maintenance therapy in newly diagnosed acute promyelocytic leukemia. The European APL Group.

Fenaux P, Chastang C, Chevret S, Sanz M, Dombret H, Archimbaud E, Fey M, Rayon C, Huguet F, Sotto JJ, Gardin C, Makhoul PC, Travade P, Solary E, Fegueux N, Bordessoule D, Miguel JS, Link H, Desablens B, Stamatoullas A, Deconinck E, Maloisel F, Castaigne S, Preudhomme C, Degos L.

Blood. 1999 Aug 15;94(4):1192-200.

3.

[Effect of post-remission therapy mainly with compound huangdai tablet on long-term survival of patients with acute promyelocytic leukemia].

Xiang Y, Chang XH, Cheng YB.

Zhongguo Zhong Xi Yi Jie He Za Zhi. 2010 Dec;30(12):1253-6. Chinese.

PMID:
21302484
4.

[Application of all-trans retinoic acid combining chemotherapy and As4S4 in the maintenance treatment of patients with acute promyelocytic leukemia].

Lin QD, Wei XD, Wang P, Liu YY, Zhang LN, Li YF, Gao QL, Zhu XH, Zhang YL, Fang BJ, Yue H, Du JW, Jiang DX, Hu JY, Song YP.

Zhonghua Xue Ye Xue Za Zhi. 2007 Jan;28(1):19-21. Chinese.

PMID:
17649720
5.

Treatment of acute promyelocytic leukaemia using a combination of all-trans retinoic acid and chemotherapy.

Koh LP, Goh YT, Teoh G, Tan P.

Ann Acad Med Singapore. 2001 Jul;30(4):401-8.

PMID:
11503549
6.

Treatment of relapsing acute promyelocytic leukemia by all-trans retinoic acid therapy followed by timed sequential chemotherapy and stem cell transplantation. APL Study Group. Acute promyelocytic leukemia.

Thomas X, Dombret H, Cordonnier C, Pigneux A, Gardin C, Guerci A, Vekhoff A, Sadoun A, Stamatoullas A, Fegueux N, Maloisel F, Cahn JY, Reman O, Gratecos N, Berthou C, Huguet F, Kotoucek P, Travade P, Buzyn A, de Revel T, Vilque JP, Naccache P, Chomienne C, Degos L, Fenaux P.

Leukemia. 2000 Jun;14(6):1006-13.

PMID:
10865965
7.

Oral tetra-arsenic tetra-sulfide formula versus intravenous arsenic trioxide as first-line treatment of acute promyelocytic leukemia: a multicenter randomized controlled trial.

Zhu HH, Wu DP, Jin J, Li JY, Ma J, Wang JX, Jiang H, Chen SJ, Huang XJ.

J Clin Oncol. 2013 Nov 20;31(33):4215-21. doi: 10.1200/JCO.2013.48.8312. Epub 2013 Oct 14.

PMID:
24127444
8.
9.

All-trans retinoic acid for the treatment of newly diagnosed acute promyelocytic leukemia. Japan Adult Leukemia Study Group.

Kanamaru A, Takemoto Y, Tanimoto M, Murakami H, Asou N, Kobayashi T, Kuriyama K, Ohmoto E, Sakamaki H, Tsubaki K, et al.

Blood. 1995 Mar 1;85(5):1202-6.

10.

[Efficacy analysis of sequential treatment with chemotherapy, ATRA and As(2)O(3) for acute promyelocytic leukemia].

Ma XJ, Ren HY, Cen XN, Qiu ZX, Wang WS, Ou JP, Wang Y, Xu WL, Li Y, Wang MJ, Wang LH, Dong YJ, Yin Y, Liang ZY.

Zhonghua Xue Ye Xue Za Zhi. 2010 May;31(5):328-32. Chinese.

PMID:
21122313
11.

All-transretinoic acid followed by intensive chemotherapy gives a high complete remission rate and may prolong remissions in newly diagnosed acute promyelocytic leukemia: a pilot study on 26 cases.

Fenaux P, Castaigne S, Dombret H, Archimbaud E, Duarte M, Morel P, Lamy T, Tilly H, Guerci A, Maloisel F, et al.

Blood. 1992 Nov 1;80(9):2176-81.

12.

Problems existing in differentiation therapy of acute promyelocytic leukemia (APL) with all-trans retinoic acid (ATRA).

Wang ZY, Chen Z, Huang W, Li XS, Lu JX, Huang LA, Zhang FQ, Gu LJ, Ouyang RR, Chen SJ, et al.

Blood Cells. 1993;19(3):633-41; discussion 642-7.

PMID:
8018944
13.

All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemia.

Shen ZX, Shi ZZ, Fang J, Gu BW, Li JM, Zhu YM, Shi JY, Zheng PZ, Yan H, Liu YF, Chen Y, Shen Y, Wu W, Tang W, Waxman S, De Thé H, Wang ZY, Chen SJ, Chen Z.

Proc Natl Acad Sci U S A. 2004 Apr 13;101(15):5328-35. Epub 2004 Mar 24.

14.

All-transretinoic acid and chemotherapy in the treatment of acute promyelocytic leukemia.

Al Bahar S, Pandita R, Bavishi K, Kreze O.

Indian J Cancer. 2004 Jul-Sep;41(3):125-8.

15.

[Stratification therapy in patients with acute promyelocytic leukemia after a complete remission by all-trans retinoic acid].

Xu JL, Jiang M, Halida Y, Duan XL, Guo XH, Hao JP, Fu ML, Qu JH, Wang L.

Zhonghua Yi Xue Za Zhi. 2011 Aug 30;91(32):2254-7. Chinese.

PMID:
22094090
16.

[Arsenic trioxide in combination with all-trans retinoic acid for acute promyelocytic leukemia: a systematic review and meta-analysis].

Xu SN, Chen JP, Liu JP, Xia Y.

Zhong Xi Yi Jie He Xue Bao. 2009 Nov;7(11):1024-34. doi: 10.3736/jcim20091102. Review. Chinese.

18.

All-trans retinoic acid therapy for newly diagnosed acute promyelocytic leukemia: comparison with intensive chemotherapy. The Japan Adult Leukemia Study Group (JALSG).

Asou N, Adachi K, Tamura J, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Sakamaki H, Tsubaki K, Saito K, Ohno R.

Cancer Chemother Pharmacol. 1997;40 Suppl:S30-5.

PMID:
9272131
19.

Treatment with all-trans retinoic acid and anthracycline monochemotherapy for children with acute promyelocytic leukemia: a multicenter study by the PETHEMA Group.

Ortega JJ, Madero L, Martín G, Verdeguer A, García P, Parody R, Fuster J, Molines A, Novo A, Debén G, Rodríguez A, Conde E, de la Serna J, Allegue MJ, Capote FJ, González JD, Bolufer P, González M, Sanz MA; PETHEMA Group.

J Clin Oncol. 2005 Oct 20;23(30):7632-40.

PMID:
16234524
20.

Analysis of prognostic factors in newly diagnosed patients with acute promyelocytic leukemia: the APL92 study of the Japan Adult Leukemia Study Group (JALSG).

Asou N, Adachi K, Tamura U, Kanamaru A, Kageyama S, Hiraoka A, Omoto E, Akiyama H, Tsubaki K, Saito K, Kuriyama K, Oh H, Kitano K, Miyawaki S, Takeyama U, Yamada O, Nishikawa K, Takahashi M, Matsuda S, Ohtake H, Ohno R.

Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S65-71.

PMID:
11587370

Supplemental Content

Support Center